A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

A common type of diabetes medication may help cancer patients ward off the risk of heart failure by 50 per cent and boost long-term recovery, according to new research on Thursday. Heart failure ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro.

Status Update All preclinical studies of Adimune’s first product candidate, ADI-100, have been completed, and the shipment of the drug substances ... in Type 1 Diabetes, Stiff Person Syndrome ...

Could a diabetes drug change cancer treatment forever? Researchers say SGLT2 inhibitors might protect cancer patients’ hearts, slashing heart failure risk and hospital stays—potentially a game-changer ...

A slow journey to drug discovery Asked about the impetus behind Verseon’s work in the sector, Prakash explained that he began the company “to change the way the world finds new drugs”.

In an observational study, SGLT2i and GLP1-RA appeared to offer the most kidney protection in real-world patients with type 2 diabetes. Patients with type 2 diabetes may have the lowest risk of ...